idazoxan has been researched along with scopolamine hydrobromide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blitzer, RD; Cornfeldt, M; Davis, L; Effland, RC; Haroutunian, V; Huger, FP; Klein, JT; Landau, E; Martin, LL; Olsen, GE; Petko, WW; Smith, CP; Wilker, JC; Wong, GS | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Aguilar-Garcia, A; Diaz-Ruiz, O; Velazquez-Moctezuma, J | 1 |
| Black, IB; Stäubli, UV; van Praag, H | 1 |
| McAllister, KH; Rey, B | 1 |
| Fukazawa, H; Ishida, H; Koda, H; Kuriyama, K; Matsumoto, N; Nukaya, H; Suwa, Y; Tsuji, K; Yokoo, Y | 1 |
| McAllister, KH | 1 |
8 other study(ies) available for idazoxan and scopolamine hydrobromide
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Biogenic Amines; Brain; In Vitro Techniques; Indoles; Magnetic Resonance Spectroscopy; Parasympatholytics; Pyridines; Rats; Structure-Activity Relationship | 1996 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Behavior, Animal; Clomipramine; Dioxanes; Female; Idazoxan; Male; Rats; Rats, Wistar; Scopolamine; Sexual Behavior, Animal; Sleep, REM | 1993 |
Neonatal vs. adult unilateral hippocampal lesions: differential alterations in contralateral hippocampal theta rhythm.
Topics: Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Functional Laterality; Hippocampus; Idazoxan; Male; Muscarinic Antagonists; Ondansetron; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Scopolamine; Serotonin Antagonists; Theta Rhythm | 1997 |
Clozapine reversal of the deficits in coordinated movement induced by D2 receptor blockade does not depend upon antagonism of alpha2 adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Ataxia; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Idazoxan; Loxapine; Male; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Scopolamine; Yohimbine | 1999 |
Antagonistic effect of N-methyltyramine on alpha2-adrenoceptor in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Idazoxan; Male; Mice; Radioligand Assay; Receptors, Adrenergic, alpha-2; Scopolamine; Tyramine | 1999 |
The alpha 2 adrenoceptor antagonists RX 821002 and yohimbine delay-dependently impair choice accuracy in a delayed non-matching-to-position task in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Idazoxan; Male; Muscarinic Antagonists; Psychomotor Performance; Rats; Scopolamine; Yohimbine | 2001 |